Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-04-02

Clinical Trial Update: Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy and tolerability of combining aripiprazole with SSRIs for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Chimei Medical Center | Conditions: Major Depressive Disorder | NA | Status: COMPLETED